BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015;15:1162-1172. [PMID: 25707744 DOI: 10.1111/ajt.13187] [Cited by in Crossref: 133] [Cited by in F6Publishing: 101] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiménez-Pérez M, González-Grande R, Mostazo Torres J, González Arjona C, Rando-Muñoz FJ. Management of hepatitis B virus infection after liver transplantation. World J Gastroenterol 2015; 21(42): 12083-12090 [PMID: 26576093 DOI: 10.3748/wjg.v21.i42.12083] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
2 Fenkel JM, Singh P, Shah AP, Frank AM. Need to consider full societal impact of hepatitis B virus-positive donors. Am J Transplant. 2015;15:3013. [PMID: 26372744 DOI: 10.1111/ajt.13450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Buzo BF, Ramos JF, Marques Rossetti RA, Salles N, Mendrone-Júnior A, Rocha V, de Seixas Santos Nastri AC. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center. Transpl Infect Dis 2020;22:e13243. [PMID: 31901206 DOI: 10.1111/tid.13243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Bhaimia E, Jung JH, Chan EL, Shah NN, Santos CAQ. Breakthrough Hepatitis B Virus Infection in a Liver Transplant Recipient on Lamivudine Prophylaxis for Donor Hepatitis B Core Antibody Seropositivity: A Review of Practices to Prevent De Novo Hepatitis B Virus Infection After Transplant. Clin Liver Dis (Hoboken) 2021;18:22-5. [PMID: 34484700 DOI: 10.1002/cld.1102] [Reference Citation Analysis]
5 OʼDonoghue KJM, Reed RD, Knight SR, OʼCallaghan JM, Ayaz-Shah AA, Hassan S, Weissenbacher A, Morris PJ, Pengel LHM. Critical Appraisal of International Clinical Practice Guidelines in Kidney Transplantation Using the Appraisal of Guidelines for Research and Education II Tool: A Systematic Review. Transplantation 2018;102:1419-39. [PMID: 30124634 DOI: 10.1097/TP.0000000000002255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lei M, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China. World J Gastroenterol 2018; 24(48): 5525-5536 [PMID: 30622380 DOI: 10.3748/wjg.v24.i48.5525] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Couri T, Aronsohn A. When Theory Becomes Reality: Navigating the Ethics of Transplanting Hepatitis C Virus-Positive Livers Into Negative Recipients. Clin Liver Dis (Hoboken) 2019;14:131-4. [PMID: 31709040 DOI: 10.1002/cld.849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Patel SS, Leung DH. Hepatitis B immunity in the pediatric liver transplant population. Curr Opin Pediatr 2016;28:653-8. [PMID: 27367054 DOI: 10.1097/MOP.0000000000000391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2019;25:93-159. [PMID: 31185710 DOI: 10.3350/cmh.2019.1002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 21.3] [Reference Citation Analysis]
10 Manas D, Burnapp L, Andrews PA. Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation. Transplantation 2016;100:1184-90. [PMID: 26950721 DOI: 10.1097/TP.0000000000001128] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.6] [Reference Citation Analysis]
11 Fischer SA. Is This Organ Donor Safe?: Donor-Derived Infections in Solid Organ Transplantation. Infect Dis Clin North Am 2018;32:495-506. [PMID: 30146019 DOI: 10.1016/j.idc.2018.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021; 13(8): 853-867 [PMID: 34552692 DOI: 10.4254/wjh.v13.i8.853] [Reference Citation Analysis]
13 Yamashiki N, Yoshizawa A, Ueda Y, Kaido T, Okajima H, Marusawa H, Seno H, Uemoto S. The use of hepatitis B immunoglobulin with or without hepatitis B vaccine to prevent de novo hepatitis B in pediatric recipients of anti-HBc-positive livers. Pediatr Transplant 2018;22:e13227. [PMID: 29761899 DOI: 10.1111/petr.13227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
14 van der Mark SC, Hoek RAS, Hellemons ME. Developments in lung transplantation over the past decade. Eur Respir Rev 2020;29:190132. [PMID: 32699023 DOI: 10.1183/16000617.0132-2019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Delman AM, Ammann AM, Shah SA. The current status of virus-positive liver transplantation. Curr Opin Organ Transplant 2021;26:160-7. [PMID: 33595981 DOI: 10.1097/MOT.0000000000000850] [Reference Citation Analysis]
16 Kim JH. 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different? Korean J Gastroenterol 2019;73:132-40. [PMID: 31013556 DOI: 10.4166/kjg.2019.73.3.132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Busch CJ, Siegler BH, Werle H, Lichtenstern C, Bruckner T, Heininger A, Mehrabi A, Weiss KH, Weigand MA, Hochreiter M. Risk factors for early viral infections after liver transplantation. Langenbecks Arch Surg 2018;403:509-19. [DOI: 10.1007/s00423-018-1672-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Van Raemdonck D, Nevens F, Van Cleemput J, Vos R, Neyrinck A, Verleden GM. Fishing in the thoracic organ donor pool: What next if the catch of the day got infected with hepatitis C virus? J Thorac Cardiovasc Surg 2020;159:2121-5. [PMID: 31837768 DOI: 10.1016/j.jtcvs.2019.08.140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Belga S, Kabbani D, Doucette K. Hepatitis B surface antigen–positive donor to negative recipient lung transplantation. Am J Transplant 2020;20:2287-8. [DOI: 10.1111/ajt.15886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Trapero-marugán M, Little EC, Berenguer M. Stretching the boundaries for liver transplant in the 21st century. The Lancet Gastroenterology & Hepatology 2018;3:803-11. [DOI: 10.1016/s2468-1253(18)30213-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
21 Pezzati D, Ghinolfi D, De Simone P, Balzano E, Filipponi F. Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol 2015; 7(26): 2636-2647 [PMID: 26609341 DOI: 10.4254/wjh.v7.i26.2636] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
22 Conway J, Ballweg JA, Fenton M, Kindel S, Chrisant M, Weintraub RG, Danziger-Isakov L, Kirk R, Meira O, Davies RR, Dipchand AI. Review of the impact of donor characteristics on pediatric heart transplant outcomes. Pediatr Transplant 2020;24:e13680. [PMID: 32198824 DOI: 10.1111/petr.13680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
23 Fischer SA. Is This Organ Donor Safe?: Donor-Derived Infections in Solid Organ Transplantation. Surg Clin North Am 2019;99:117-28. [PMID: 30471737 DOI: 10.1016/j.suc.2018.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
24 Park JS, Gayam V, Pan CQ. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals. Aliment Pharmacol Ther. 2020;52:944-954. [PMID: 32743822 DOI: 10.1111/apt.15999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Veroux M, Ardita V, Corona D, Giaquinta A, Ekser B, Sinagra N, Zerbo D, Patanè M, Gozzo C, Veroux P. Kidney Transplantation From Donors with Hepatitis B. Med Sci Monit 2016;22:1427-34. [PMID: 27123988 DOI: 10.12659/msm.896048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Fung SKS, Chau KF, Chow KM. Clinical practice guidelines for the provision of renal service in Hong Kong: Potential Kidney Transplant Recipient Wait-listing and Evaluation, Deceased Kidney Donor Evaluation, and Kidney Transplant Postoperative Care. Nephrology (Carlton) 2019;24 Suppl 1:60-76. [PMID: 30900332 DOI: 10.1111/nep.13502] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Aslam S, Yumul I, Mariski M, Pretorius V, Adler E. Outcomes of heart transplantation from hepatitis C virus–positive donors. The Journal of Heart and Lung Transplantation 2019;38:1259-67. [DOI: 10.1016/j.healun.2019.08.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
28 Buganza-torio E, Doucette KE. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018;32:635-50. [DOI: 10.1016/j.idc.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
29 Grissom TE, Richards JE, Herr DL. Critical Care Management of the Potential Organ Donor. Int Anesthesiol Clin 2017;55:18-41. [PMID: 28230718 DOI: 10.1097/AIA.0000000000000137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Loggi E, Conti F, Cucchetti A, Ercolani G, Pinna AD, Andreone P. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature. World J Gastroenterol 2016; 22(35): 8010-8016 [PMID: 27672295 DOI: 10.3748/wjg.v22.i35.8010] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
31 Nicastro E, Norsa L, Di Giorgio A, Indolfi G, D'Antiga L. Breakthroughs and challenges in the management of pediatric viral hepatitis. World J Gastroenterol 2021; 27(20): 2474-2494 [PMID: 34092970 DOI: 10.3748/wjg.v27.i20.2474] [Reference Citation Analysis]
32 Soin AS, Chaudhary RJ, Pahari H, Pomfret EA. A Worldwide Survey of Live Liver Donor Selection Policies at 24 Centers With a Combined Experience of 19 009 Adult Living Donor Liver Transplants. Transplantation 2019;103:e39-47. [DOI: 10.1097/tp.0000000000002475] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
33 Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M; INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol 2018;8:58-80. [PMID: 29743798 DOI: 10.1016/j.jceh.2017.12.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
34 Blumberg EA. Prevention of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices: A summary of the MMWR report. Am J Transplant 2018;18:1285-6. [DOI: 10.1111/ajt.14763] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Werbel WA, Durand CM. Pro: Use of Hepatitis C Virus-Positive Donors Should Be Considered Standard of Care. Clin Liver Dis (Hoboken) 2018;12:100-4. [PMID: 30988922 DOI: 10.1002/cld.743] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
36 Orfanidou A, Papatheodoridis GV, Cholongitas E. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver Int 2021;41:1448-61. [PMID: 33656809 DOI: 10.1111/liv.14860] [Reference Citation Analysis]
37 Wei L, Chen D, Zhang B, Zhao Y, Liu B, Shi H, Zeng F, Ming C, Jiang J, Du D, Chen Z. Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population. J Viral Hepat 2018;25:1576-81. [PMID: 30009520 DOI: 10.1111/jvh.12972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Kwan KW, Lim TR, Kumar R, Krishnamoorthy TL. Understanding the hepatitis B core positive liver donor. Singapore Med J. 2018;. [PMID: 30182132 DOI: 10.11622/smedj.2018104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Theodoropoulos NM, La Hoz RM, Wolfe C, Vece G, Bag R, Berry GJ, Bucio J, Danziger-Isakov L, Florescu DF, Goldberg D, Ho CS, Lilly K, Malinis M, Mehta AK, Nalesnik MA, Sawyer R, Strasfeld L, Wood RP, Michaels MG. Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee. Transpl Infect Dis 2021;23:e13458. [PMID: 32894634 DOI: 10.1111/tid.13458] [Reference Citation Analysis]
40 Lee S, Kim JM, Choi GS, Park JB, Kwon CH, Choe YH, Joh JW, Lee SK. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers. Liver Transpl. 2016;22:247-251. [PMID: 26600319 DOI: 10.1002/lt.24372] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
41 Burton CE, Doucette KE, Mabilangan CA, Plitt SS, Lee BE, Preiksaitis JK. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center. Transpl Infect Dis 2016;18:520-8. [PMID: 27226204 DOI: 10.1111/tid.12558] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Winterbottom F, Jenkins M. Infections in the Intensive Care Unit: Posttransplant Infections. Crit Care Nurs Clin North Am 2017;29:97-110. [PMID: 28160960 DOI: 10.1016/j.cnc.2016.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
43 Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018;102:S66-71. [PMID: 29381580 DOI: 10.1097/TP.0000000000002013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Arora S, Kipp G, Bhanot N, Sureshkumar KK. Vaccinations in kidney transplant recipients: Clearing the muddy waters. World J Transplantation 2019; 9(1): 1-13 [PMID: 30697516 DOI: 10.5500/wjt.v9.i1.1] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
45 L'Huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review. Hum Vaccin Immunother 2015;11:2852-63. [PMID: 26291740 DOI: 10.1080/21645515.2015.1078043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
46 Chancharoenthana W, Leelahavanichkul A, Udomkarnjananun S, Wattanatorn S, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Townamchai N. Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study. Open Forum Infect Dis 2019;6:ofy342. [PMID: 30697573 DOI: 10.1093/ofid/ofy342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
48 Theodoropoulos N, Nowicki MJ, Chinchilla-reyes C, Dionne S, Jaramillo A, Mone T, Hasz R, Jendrisak MD, Ladner DP, Ison MG. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results. Transpl Infect Dis 2018;20:e12821. [DOI: 10.1111/tid.12821] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
49 Jandhyala D, Lewis JD. An Analysis of Adherence to Vaccination Recommendations in a Thoracic Organ Transplant Cohort. Vaccines (Basel) 2020;8:E622. [PMID: 33105698 DOI: 10.3390/vaccines8040622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 White SL, Rawlinson W, Boan P, Sheppeard V, Wong G, Waller K, Opdam H, Kaldor J, Fink M, Verran D, Webster A, Wyburn K, Grayson L, Glanville A, Cross N, Irish A, Coates T, Griffin A, Snell G, Alexander SI, Campbell S, Chadban S, Macdonald P, Manley P, Mehakovic E, Ramachandran V, Mitchell A, Ison M. Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission. Transplant Direct 2019;5:e416. [PMID: 30656214 DOI: 10.1097/TXD.0000000000000852] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
51 Vertanous T, Czer LS, de Robertis M, Kiankhooy A, Kobashigawa J, Esmailian F, Trento A. Leading Efforts to Increase Organ Donation Through Professionalization of Organ Procurement Organizations and Establishment of Organ and Tissue Donor Registries. Transplant Proc 2016;48:10-4. [PMID: 26915835 DOI: 10.1016/j.transproceed.2015.12.029] [Reference Citation Analysis]
52 van den Hoogen MWF, Seghers L, Manintveld OC, Roest S, Bekkers JA, den Hoed CM, Minnee RC, de Geus HRH, van Thiel RJ, Hesselink DA. Care for the organ transplant recipient on the intensive care unit. J Crit Care 2021;64:37-44. [PMID: 33784577 DOI: 10.1016/j.jcrc.2021.03.003] [Reference Citation Analysis]
53 Ravaioli M, Grande G, Di Gioia P, Cucchetti A, Cescon M, Ercolani G, Del Gaudio M, Morelli C, Pinna AD. Risk Avoidance and Liver Transplantation: A Single-center Experience in a National Network. Annals of Surgery 2016;264:778-86. [DOI: 10.1097/sla.0000000000001887] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Delman AM, Turner KM, Safdar K, Anwar N, Silski LS, Lee TC, Luckett K, Cuffy MC, Quillin RC 3rd, Schoech M, Kaiser TE, Govil A, Bari K, Shah SA. Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients. Ann Surg 2021;274:556-64. [PMID: 34506310 DOI: 10.1097/SLA.0000000000005071] [Reference Citation Analysis]
55 Vandendriessche K, Nevens F, Van Cleemput J, Van Raemdonck D, Rega F. Commentary: Hepatitis: A way to make organ donation go viral? J Thorac Cardiovasc Surg 2019;158:554-5. [PMID: 31196756 DOI: 10.1016/j.jtcvs.2019.02.141] [Reference Citation Analysis]
56 Brown K. Maximizing donors with viral hepatitis in the current era. Liver Transpl 2017;23:S44-9. [PMID: 28846183 DOI: 10.1002/lt.24863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Corey AB, Sonetti D, Maloney JD, Montgomery SP, Rademacher BL, Taylor LJ, Smith JA, Striker R. Transmission of Donor-Derived Trypanosoma cruzi and Subsequent Development of Chagas Disease in a Lung Transplant Recipient. Case Rep Infect Dis 2017;2017:5381072. [PMID: 28912986 DOI: 10.1155/2017/5381072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Sawinski D, Blumberg EA. Infection in Renal Transplant Recipients. Chronic Kidney Disease, Dialysis, and Transplantation. Elsevier; 2019. pp. 621-638.e6. [DOI: 10.1016/b978-0-323-52978-5.00040-9] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Fürnkranz U, Walochnik J. Nosocomial Infections: Do Not Forget the Parasites! Pathogens 2021;10:238. [PMID: 33669761 DOI: 10.3390/pathogens10020238] [Reference Citation Analysis]
60 Lee TC, Eckman MH, Shah SA. Cost-Effectiveness of Utilization of Hepatitis B Virus-Positive Liver Donors for HBV-Negative Transplant Recipients. J Gastrointest Surg 2021;25:1760-9. [DOI: 10.1007/s11605-020-04759-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Wang XD, Feng SJ, Liu JP, Song TR, Huang ZL, Fan Y, Shi YY, Chen LY, Lv YH, Xu ZL, Li XH, Wang L, Lin T. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients. BMC Infect Dis 2021;21:41. [PMID: 33422017 DOI: 10.1186/s12879-020-05704-1] [Reference Citation Analysis]
62 Ansari S, Bromberg MB, Gibson SB. Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis. Clin Neurol Neurosurg 2017;160:125-9. [PMID: 28727995 DOI: 10.1016/j.clineuro.2017.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
63 Fernández I, Pascasio JM, Colmenero J; en nombre del grupo de trabajo para el VII consenso de la SETH., Autores participantes en el grupo de trabajo en representación de sus respectivos programas de trasplante hepático. Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation. Gastroenterol Hepatol 2020;43:169-77. [PMID: 32094045 DOI: 10.1016/j.gastrohep.2019.11.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Udayakumar VP, Surendran S, Padma UD. Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation. Indian J Gastroenterol 2018;37:39-43. [PMID: 29450703 DOI: 10.1007/s12664-018-0823-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
65 Cornberg M, Sandmann L, Protzer U, Niederau C, Tacke F, Berg T, Glebe D, Jilg W, Wedemeyer H, Wirth S, Höner Zu Siederdissen C, Lynen-Jansen P, van Leeuwen P, Petersen J; Collaborators:. S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11). Z Gastroenterol 2021;59:691-776. [PMID: 34255317 DOI: 10.1055/a-1498-2512] [Reference Citation Analysis]
66 Te H, Doucette K. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13514] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
67 Smibert OC, Paraskeva MA, Westall G, Snell G. An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients. Paediatr Drugs 2018;20:539-53. [PMID: 30187362 DOI: 10.1007/s40272-018-0313-1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
68 Kayaaslan B, Guner R. Adverse effects of oral antiviral therapy in chronic hepatitis B. World J Hepatol 2017; 9(5): 227-241 [PMID: 28261380 DOI: 10.4254/wjh.v9.i5.227] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
69 Khush KK. Donor selection in the modern era. Ann Cardiothorac Surg 2018;7:126-34. [PMID: 29492390 DOI: 10.21037/acs.2017.09.09] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
70 Paulsen MR, Patel NR, Sulis C, Farraye FA, Bhat S. Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists. J Pharm Pract 2020;:897190020958261. [PMID: 32938309 DOI: 10.1177/0897190020958261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Han S, Na GH, Kim DG. A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis. Drug Des Devel Ther 2017;11:2099-107. [PMID: 28744101 DOI: 10.2147/DDDT.S134711] [Reference Citation Analysis]
72 Verna EC. Vaccination to prevent de novo hepatitis B: Are there patients who do not need antiviral prophylaxis? Liver Transpl 2017;23:1253-4. [DOI: 10.1002/lt.24858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
73 Badawy A, Kaido T, Uemoto S. Current Status of Liver Transplantation Using Marginal Grafts. Journal of Investigative Surgery 2020;33:553-64. [DOI: 10.1080/08941939.2018.1517197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Kotton CN, van Delden C. Prevention of Bacterial, Viral, Fungal, and Parasitic Infections During the Early Post-transplant Period. In: Manuel O, Ison MG, editors. Infectious Diseases in Solid-Organ Transplant Recipients. Cham: Springer International Publishing; 2019. pp. 39-50. [DOI: 10.1007/978-3-030-15394-6_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Kling CE, Limaye AP, Landis CS, Sibulesky L. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue. Clin Transplant 2017;31. [PMID: 28130837 DOI: 10.1111/ctr.12884] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
76 Len O, Los-Arcos I, Aguado JM, Blanes M, Bodro M, Carratalà J, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Gavaldà J, López-Medrano F, López-Vélez R, Lumbreras C, Mahillo B, Marcos MÁ, Martin-Dávila P, Montejo JM, Moreno A, Muñoz P, Norman F, Pérez-Sáenz JL, Pumarola T, Sabé N, San-Juan R, Vidal E, Domínguez-Gil B; Grupo de Estudio de la Infección en el Trasplante (GESITRA) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) and the Organización Nacional de Trasplantes (ONT). Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus. Transplant Rev (Orlando) 2020;34:100528. [PMID: 32001103 DOI: 10.1016/j.trre.2020.100528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Yuan Q, Haque O, Hong S, Ortiz A, Bethea ED, Sise ME, Markmann JF, Elias N. Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant 2021;:e14466. [PMID: 34545965 DOI: 10.1111/ctr.14466] [Reference Citation Analysis]
78 Yang Y, Huang A, Zhao Y. Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis. Hepatol Int 2020;14:202-11. [PMID: 32100260 DOI: 10.1007/s12072-020-10021-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Nam H, Nilles KM, Levitsky J, Ison MG. Donor-derived Viral Infections in Liver Transplantation. Transplantation 2018;102:1824-36. [PMID: 29979345 DOI: 10.1097/TP.0000000000002326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
80 Zhou K, Zhou S. Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors. Curr Opin Organ Transplant 2020;25:631-9. [PMID: 33027191 DOI: 10.1097/MOT.0000000000000810] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Vitrone M, Iossa D, Rinaldi L, Pafundi PC, Molaro R, Parrella A, Andini R, Ragone E, Maiello C, Zampino R, Durante-Mangoni E. Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact. J Clin Virol 2017;96:54-9. [PMID: 28964958 DOI: 10.1016/j.jcv.2017.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
82 Sánchez Ibáñez J, Vilarrodona Serrat A, Seoane Pillado T, Rodriguez Aierbe C, Villalba Montoro R, Calvo Benito J, Pevida Lopez M, Fernández Paneque S, Vuelta Lopez E, Martínez Lorenzo MJ, González Romero M, Cañizares Castellanos A, Sauleda Oliveras S. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain. Cell Tissue Bank 2019;20:513-26. [PMID: 31451994 DOI: 10.1007/s10561-019-09784-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 Hammami MB, Kohli R, Woreta T, Sulkowski MS, Hamilton JP, Toman L, Saberi B, Laurin J, Wang JG, Philosophe B, Cameron AM, Gurakar A. Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. ACG Case Rep J 2021;8:e00582. [PMID: 34549060 DOI: 10.14309/crj.0000000000000582] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Duvoux C, Belli LS, Fung J, Angelico M, Buti M, Coilly A, Cortesi P, Durand F, Féray C, Fondevila C, Lebray P, Martini S, Nevens F, Polak WG, Rizzetto M, Volpes R, Zoulim F, Samuel D, Berenguer M. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation. Aliment Pharmacol Ther 2021;54:583-605. [PMID: 34287994 DOI: 10.1111/apt.16374] [Reference Citation Analysis]
85 Wang Q, Klenerman P, Semmo N. Significance of anti-HBc alone serological status in clinical practice. The Lancet Gastroenterology & Hepatology 2017;2:123-34. [DOI: 10.1016/s2468-1253(16)30076-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 4.2] [Reference Citation Analysis]
86 Kim KD, Lee JE, Kim JM, Lee O, Hwang NY, Rhu J, Choi GS, Kim K, Joh JW. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea. Clin Mol Hepatol 2021;27:603-15. [PMID: 34492755 DOI: 10.3350/cmh.2021.0137] [Reference Citation Analysis]
87 Arora A, Anand AC, Kumar A, Singh SP, Aggarwal R, Dhiman RK, Aggarwal S, Alam S, Bhaumik P, Dixit VK, Goel A, Goswami B, Kumar A, Kumar M, Madan K, Murugan N, Nagral A, Puri AS, Rao PN, Saraf N, Saraswat VA, Sehgal S, Sharma P, Shenoy KT, Wadhawan M; Members of the INASL taskforce on Hepatitis B. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. J Clin Exp Hepatol 2018;8:403-31. [PMID: 30568345 DOI: 10.1016/j.jceh.2018.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
88 Kuczaj A, Warwas S, Przybyłowski P, Zembala M. Heart Retransplantation From an Hepatitis B Core Antibody (Anti-HBcore)-Positive Donor: A Case Report. Transplant Proc 2021;53:1369-70. [PMID: 33551187 DOI: 10.1016/j.transproceed.2020.11.011] [Reference Citation Analysis]
89 Wang X, Liu J, Song T, Huang Z, Fan Y, Shi Y, Chen L, Lv Y, Xu Z, Li X, Wang L, Lin T. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)–Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China. Clinical Infectious Diseases 2021;72:1016-23. [DOI: 10.1093/cid/ciaa178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
90 Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract 2018;37:323-37. [PMID: 30619688 DOI: 10.23876/j.krcp.18.0063] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
91 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398. [PMID: 28427875 DOI: 10.1016/j.jhep.2017.03.021] [Cited by in Crossref: 1805] [Cited by in F6Publishing: 1711] [Article Influence: 361.0] [Reference Citation Analysis]
92 Sticchi L, Iavarone IG, Durando P, Di Biagio A, Schiavetti I, Murgia F, Icardi G. The role of hepatitis B vaccine challenge dose in patients with underlying health conditions. Hum Vaccin Immunother 2021;17:575-9. [PMID: 32614653 DOI: 10.1080/21645515.2020.1777058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Waller KMJ, Wyburn KR, Shackel NA, O'Leary MJ, Kelly PJ, Webster AC. Hepatitis Transmission Risk in Kidney Transplantation (the HINT study): A Cross-Sectional Survey of Transplant Clinicians in Australia and New Zealand. Transplantation 2018;102:146-53. [PMID: 28731903 DOI: 10.1097/TP.0000000000001885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Sypek MP, Alexander SI, Cantwell L, Ierino FL, Ferrari P, Walker AM, Kausman JY. Optimizing Outcomes in Pediatric Renal Transplantation Through the Australian Paired Kidney Exchange Program. Am J Transplant 2017;17:534-41. [DOI: 10.1111/ajt.14041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
95 Kim IC, Youn JC, Kobashigawa JA. The Past, Present and Future of Heart Transplantation. Korean Circ J 2018;48:565-90. [PMID: 29968430 DOI: 10.4070/kcj.2018.0189] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
96 Kotton CN, Huprikar S, Kumar D. Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data. Am J Transplant 2017;17:1439-46. [DOI: 10.1111/ajt.14195] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
97 Fallahzadeh MA, Trotter JF. An Experiment of Nature: HBV-naive Recipients Receiving Liver Grafts With HBV Core Antibody-positive Donors Without Antiviral Prophylaxis. Transplantation 2020;104:e245-6. [PMID: 32732858 DOI: 10.1097/TP.0000000000003233] [Reference Citation Analysis]
98 Ling Q, Liu J, Zhuo J, Zhuang R, Huang H, He X, Xu X, Zheng S. Development of models to predict early post-transplant recurrence of hepatocellular carcinoma that also integrate the quality and characteristics of the liver graft: A national registry study in China. Surgery 2018:S0039-6060(18)30079-5. [PMID: 29709370 DOI: 10.1016/j.surg.2018.01.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Chen PH, Limketkai BN, Trilianos P, Pirtini-Cetingul M, Woreta TA, Kim B, Gulsen MT, Segev DL, Cameron AM, Gurakar A. Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation. Clin Transplant 2016;30:579-88. [PMID: 26913379 DOI: 10.1111/ctr.12723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
100 Yang A, Guo Z, Ren Q, Wu L, Ma Y, Hu A, Wang D, Ye H, Zhu X, Ju W, He X. Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study. PLoS One 2017;12:e0188190. [PMID: 29145470 DOI: 10.1371/journal.pone.0188190] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
101 Khemichian S, Kahn J, Terrault NA. Use of Hepatitis B Virus-Positive Organs in Organ Transplantation. Clin Liver Dis 2021;25:841-57. [PMID: 34593157 DOI: 10.1016/j.cld.2021.06.009] [Reference Citation Analysis]
102 Chancharoenthana W, Leelahavanichkul A. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Benefits and Risks. Clin Infect Dis 2021;72:720-1. [PMID: 32492130 DOI: 10.1093/cid/ciaa707] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Sawinski D, Wong T, Goral S. Current state of kidney transplantation in patients with HIV, hepatitis C, and hepatitis B infection. Clin Transplant 2020;34:e14048. [PMID: 32700341 DOI: 10.1111/ctr.14048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
104 Wang Y, Cai J, Sun Y, Zhang J, Xie F, Alshirbini MH, Shi J, Dong N. Extended donor criteria in heart transplantation: a retrospective study from a single Chinese institution. J Thorac Dis 2018;10:2153-65. [PMID: 29850119 DOI: 10.21037/jtd.2018.03.149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
105 Malinis M, Boucher HW; on behalf of the AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13548] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 12.7] [Reference Citation Analysis]
106 Gajurel K, Stapleton JT. Hepatitis Viruses in Kidney Transplantation. Seminars in Nephrology 2016;36:386-96. [DOI: 10.1016/j.semnephrol.2016.05.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
107 Indolfi G, Abdel-Hady M, Bansal S, Debray D, Smets F, Czubkowski P, van der Woerd W, Samyn M, Jahnel J, Gupte G, Zellos A, Mozer-Glassberg Y, Verkade HJ, Sokal E, Fischler B. Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies. J Pediatr Gastroenterol Nutr. 2020;70:527-538. [PMID: 31977956 DOI: 10.1097/mpg.0000000000002628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
108 Lee TC, Kaiser TE, Luckett K, Wima K, Winer LK, Morris MC, Kassam A, Safdar K, Bari K, Anwar N, Quillin RC, Shah SA. Use, Safety, and Effectiveness of Viremic Hepatitis B Virus Donor Livers: A Potential Opportunity to Expand the Donor Pool. Liver Transpl 2019;25:1581-4. [DOI: 10.1002/lt.25595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]